VentriLabs secures Vinnova funding for more efficient biopharmaceutical manufacturing
Gothenburg-based VentriLabs has secured Vinnova funding to evaluate its innovative DuaFLO® BioPump at KTH Royal Institute of Technology. Previous independent tests showed up to 25% higher antibody productivity compared with a conventional pump. The new study aims to validate the technology's potential to make biopharmaceutical manufacturing more efficient and scalable.